4.6 Article

Transglutaminase 2 Is Needed for the Formation of an Efficient Phagocyte Portal in Macrophages Engulfing Apoptotic Cells

期刊

JOURNAL OF IMMUNOLOGY
卷 182, 期 4, 页码 2084-2092

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0803444

关键词

-

资金

  1. National Research Fund [OTKA T T049445, TS-44798, F-67632]
  2. Ministry of Welfare [T 115/2006]
  3. European Union [MRTN-CT-2006-036032, MRTN-CT2006-035624, LSHB-CT-2007-037730]
  4. Action Medical Research, U.K [AP1043]
  5. MRC [MC_U132670600] Funding Source: UKRI
  6. Medical Research Council [MC_U132670600] Funding Source: researchfish

向作者/读者索取更多资源

Transglutaminase 2 (TG2), a protein cross-linking enzyme with many additional biological functions, acts as coreceptor for integrin beta(3). We have previously shown that TG2(-/-) mice develop an age-dependent autoimmunity due to defective in vivo clearance of apoptotic cells. Here we report that TG2 on the cell surface and in guanine nucleotide-bound form promotes phagocytosis. Besides being a binding partner for integrin beta(3), a receptor known to mediate the uptake of apoptotic cells via activating Rac1, we also show that TG2 binds MFG-E8 (milk fat globulin EGF factor 8), a protein known to bridge integrin beta(3), to apoptotic cells. Finally, we report that in wild-type macrophages one or two engulfing portals are formed during phagocytosis of apoptotic cells that are characterized by accumulation of integrin beta(3) and Rac1. In the absence of TG2, integrin beta(3), cannot properly recognize the apoptotic cells, is not accumulated in the phagocytic cup, and its signaling is impaired. As a result, the formation of the engulfing portals, as well as the portals formed, is much less efficient. We propose that TG2 has a novel function to stabilize efficient phagocytic portals. The Journal of Immunology, 2009, 182: 2084-2092.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据